The researchers were interested in the effect on cancer growth of a common immunotherapy targeting a molecule called PD-1 on immune ... blocking the EPO signaling pathway and anti-PD-1 pathway.

Anti-PD-1 therapies, including one marketed commercially ... the combinatorial effect of simultaneously blocking the EPO signaling pathway and anti-PD-1 pathway. In those experiments, no mice ...